| 영문 | basal metabolic rate(BMR) | 한글 | 기초대사율 |
|---|---|---|---|
| 설명 | 표준 기초대사량과 비교했을 때 개체 기초대사량이 보이는 편차를 표시하는 지수. 기초대사량은 생명을 유지하는데 필요한 최소한의 에너지 대사량이며, 성과 연령이 동일한 건강인의 기초대사량은 체표면적에 비례한다. 이것을 체표면적의 법칙이라고 하며, 1882년 독일의 대사생리학자 M. 브루너에 의해 제창되었다. 체표면적은 신장과 체중에 의해 산출된다. 따라서 성-연령-신장-체중을 알면 표준기초량 Y가 산출되고 실제의 기초대사량 X는 산소소비량과 이산화탄소 발생량에서 산출된다. 그리고 X와 Y의 차이를 Y로 나눈 값(%)을 기초대사율이라고 한다. 경험적으로 얻은 BMR의 간단한 측정법도 있으며 다음과 같은 식으로 구한다. 이 식에서 맥폭이란 최고혈압과 최저혈압의 차를 말한다. BMR(%)=0.75(1분 맥박수 + 0.74×맥폭)－72. BMR이 10% 이내이면 정상범위, +10% 이상이면 기초대사항진, －10% 이하이면 기초대사 저하라고 한다. 기초대사는 공복시(식후 10시간 경과)에 안정된 상태에서 단위 시간당 이용되는 에너지의 양, 즉, 한 시간당, 몸 표면의 1m2당 또는 몸무게 1kg 당 칼로리로 나타낸다. 이것은 개인에 따라 다르며 장기간에는 거의 변화가 없지만 질병 등으로 인해 변동된다. 실측한 기초대사를 표준치와 비교함으로써 질병의 진단 등에 응용할 수 있다 BMR=(실측치-표준치)/표준치 ×100(%)로 나타낸다. |
||
| AACC | American Association for Clinical Chemistry |
|---|---|
| ARSC | arylsulfatase C; Associate of the Royal Society of Chemistry |
| chem | chemistry, chemical; chemotherapy |
| CSCV | critical serum chemistry value |
| CSP | carotid sinus pressure; cavum septi pellucidi; cell surface protein; cerebrospinal protein; Chartere... |
| I.F.C.C. | International Federation of Clinical Chemistry |
|---|---|
| IUPAC | International Union of Pure and Applied Chemistry |
| ADMR | Average daily metabolic rate |
| BMR | Basal Metabolic Rate |
| CMRGlu | Cerebral Metabolic Rate of Glucose |
| basal metabolic rate | <biochemistry, biology> The metabolic rate as measured under basal conditions: 12 hours after eating, after a restful sleep, no exercise or activity preceding test, elimination of emotional excitement and occurring in a comfortable temperature. Acronym: BMR (15 Nov 1997) |
|---|---|
| brain diseases, metabolic | Metabolic disorders which lead to pathological changes and/or functional deviations of the brain. (12 Dec 1998) |
| rate, basal metabolic | A measure of the rate of metabolism. For example, someone with an overly active thyroid will have an elevated basal metabolic rate. (12 Dec 1998) |
| metabolic | 1. <biology> Of or pertaining to metamorphosis; pertaining to, or involving, change. 2. <physiology> Of or pertaining to metabolism; as, metabolic activity; metabolic force. Source: Websters Dictionary (01 Mar 1998) |
| metabolic acidosis | <biochemistry> A metabolic derangement of acid-base balance where the blood pH is abnormally low. Causes include haemorrhagic shock, cardiogenic shock, severe dehydration, sepsis, toxic ingestion (for example isopropyl alcohol, methanol), alcoholic ketoacidosis, lactic acidosis, renal failure and diabetic ketoacidosis. Respiratory acidosis will occur if the lungs are not ventilating properly. (27 Jun 1999) |
| metabolic alkalosis | <biochemistry> A metabolic derangement where the pH of the blood is abnormally high (basic). This condition may result from hyperventilation, the use of a particular drug, excessive vomiting or dehydration (contraction alkalosis). (27 Jun 1999) |
| metabolic burst | <biochemistry> Response of phagocytes to particles (particularly if opsonise d) and to agonists such as formyl peptides and phorbol esters, an enhanced uptake of oxygen leads to the production, by an NADH dependent system, of hydrogen peroxide, superoxide anions and hydroxyl radicals, all of which play a part in bactericidal activity. Defects in the metabolic burst, as in chronic granulomatous disease, predispose to infection particularly with catalase positive bacteria and are usually fatal in childhood. (27 Jun 1999) |
| metabolic calculus | A stone, usually a renal stone, caused by a metabolic abnormality resulting in increased excretion of a substance of low solubility in urine, such as urate or cystine. (05 Mar 2000) |
| metabolic clearance rate | Volume of biological fluid completely cleared of drug metabolites as measured in unit time. Elimination occurs as a result of metabolic processes in the kidney, liver, saliva, sweat, intestine, heart, brain, or other site. (12 Dec 1998) |
| metabolic coma | Coma resulting from diffuse failure of neuronal metabolism, caused by such abnormalities as intrinsic disorders of neuron or glial cell metabolism, or extracerebral disorders that produce intoxication or electrolyte imbalances. (05 Mar 2000) |
| metabolic cooperation | <cell biology, molecular biology> Transfer between tissue cells in contact of low molecular weight metabolites such as nucleotides and amino acids. Transfer is via channels constituted by the connexons of gap junctions and does not involve exchange with the extracellular medium. First observed in cultures of animal cells in which radio labelled purines were transferred from wild type cells to mutants unable to utilise exogenous purines. (27 Jun 1999) |
| metabolic coupling | <cell biology, molecular biology> Transfer between tissue cells in contact of low molecular weight metabolites such as nucleotides and amino acids. Transfer is via channels constituted by the connexons of gap junctions and does not involve exchange with the extracellular medium. First observed in cultures of animal cells in which radio labelled purines were transferred from wild type cells to mutants unable to utilise exogenous purines. (27 Jun 1999) |
| metabolic craniopathy | <syndrome> Hyperostosis frontalis interna in elderly women, with obesity and neuropsychiatric disorders of uncertain cause; at least sometimes familial. Synonym: metabolic craniopathy, Stewart-Morel syndrome. (05 Mar 2000) |
| metabolic detoxication, drug | Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion. (12 Dec 1998) |
| metabolic disease | Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (metabolism, inborn errors) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|